Overcoming Missed Opportunities in the Management of Concurrent Anemia in IBD—Assessing Strategies to Treat Anemia in IBD: Meet Helen
This activity is supported by an independent educational grant from Pfizer Inc.
Activity Release Date: 10/24/2019
Activity Expiration Date: 10/24/2020
Jointly provided by and
Anemia is a common condition. In the United States, anemia is number 15 of the top 20 hospital diagnoses for emergency department visits, accounting for about 285,000 annual emergency room visits.1 Although the incidence of anemia in patients with inflammatory bowel disease (IBD), which comprises ulcerative colitis and Crohn’s disease, has reportedly decreased in the last few decades, it is still the most prevalent extraintestinal complication of IBD. Anemia is an important factor in the overall well-being of IBD patients and frequently does not receive the attention it deserves.
Using clinical case scenarios, this activity (one of two to be released 30-days apart) will improve learners’ knowledge and competence regarding the
- Recognition and significance of anemia in general and in adult patients with IBD
- Impact of anemia on the quality of life of patients with IBD
- Significance of anemia as an indicator of disease activity
- Anemia care pathways and the need for actively supported anemia treatment with different IBD regimens
- Benefit of engaging patients with IBD anemia in shared-decision-making National Hospital Ambulatory Medical Care Survey: 2015. Available at https://www.cdc.gov/nchs/data/nhamcs/web_tables/2015_ed_web_tables.pdf.
This curriculum will be designed to meet the educational needs of gastroenterologists, internal medicine physicians, family medicine physicians, gastroenterology fellows, nurse practitioners, and physician assistants involved in the care and treatment of adult patients with IBD.
Upon completion of the educational activity, participants should be able to:
- Describe the factors that contribute to the development of anemia in adult patients with IBD.
- Identify the signs and symptoms of anemia and describe the impact on adult patients with IBD.
- Assess strategies to treat iron-deficiency anemia and anemia of chronic disease in adult patients with IBD to optimize IBD treatment and improve quality of life.
- Evaluate how an anemia care pathway can be incorporated into practice to improve screening, evaluation, treatment and follow-up care of anemia in adult patients with IBD.
Criteria for Success
Statements of credit will be awarded based on the participant reviewing each presentation, scoring a 70% on the post test, and completing and submitting an activity evaluation. A statement of credit will be available upon completion of an online evaluation/claimed credit form. You must participate in the entire activity to receive credit. There is no fee to participant in this activity. If you have questions about this CME activity, please contact AKH Inc. at firstname.lastname@example.org.
CME Credit provided by AKH Inc., Advancing Knowledge in Healthcare
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of AKH Inc., Advancing Knowledge in Healthcare and peerXchange Inc. AKH Inc., Advancing Knowledge in Healthcare is accredited by the ACCME to provide continuing medical education for physicians.
AKH Inc., Advancing Knowledge in Healthcare designates this enduring activity for a maximum of 0.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
NCCPA accepts AMA PRA Category 1 Credit™ from organizations accredited by ACCME.
Michael D. Cirigliano, MD, FACP, discloses no financial relationships with pharmaceutical or medical product manufacturers.
Gary R. Lichtenstein, MD, has disclosed the following relevant financial relationships:
Consultant - Abbvie, American Regent / Luitpold, Celgene, CellCeutrix, Eli Lilly, Ferring, Gilead, Janssen Orthobiotech (Funding to University of PA - IBD Fellow Education), Pfizer Pharmaceuticals (Funding to University of PA - IBD Fellow Education), Prometheus Laboratories, Inc., Romark, Salix Pharmaceuticals/Valeant, Shire Pharmaceuticals, Takeda (Funding to University of PA - IBD Fellow Education), UCB
Contracted Research - Celgene, Janssen Orthobiotech (Funding to University of PA - IBD Fellow Education), Salix Pharmaceuticals/Valeant, Shire Pharmaceuticals, UCB
Other - American College of Gastroenterology (Honorarium for Associate Editor of American Journal of Gastroenterology), American Regent / Luitpold (CME Program Support) Clinical Advances in Gastroenterology Editor, Eli Lilly (Data Safety Monitoring Board), Gastroenterology and Hepatology (Gastro-Hep Communications) - Editor (Honorarium), McMahon Publishing- Author (Honorarium), Merck (Honorarium for CME Program), Romark (Honorarium for CME Program), SLACK, Inc (Book Royalty), Springer Science and Business Media Editor (Honorarium), Up-To-Date- Author (Honorarium)
Staff and Reviewers Disclosures
Dorothy Caputo, MA, BSN, RN, Lead Nurse Planner/Reviewer, discloses no financial relationships with pharmaceutical or medical product manufacturers.
Patricia Brignoni, AKH Director of Operations/Reviewer, discloses no financial relationships with pharmaceutical or medical product manufacturers.
Wendy Gloffke, PhD, Medical Writer, discloses no financial relationships with pharmaceutical or medical product manufacturers.
AKH Inc. and peerXchange Inc. planners and reviewers have no relevant financial relationships to disclose.
This activity is supported by an independent educational grant from Pfizer Inc.
It is the policy of AKH Inc. and peerXchange Inc. to ensure independence, balance, objectivity, scientific rigor, and integrity in all of its continuing education activities. The faculty must disclose to the participants any significant relationships with commercial interests whose products or devices may be mentioned in the activity or with the commercial supporter of this continuing education activity. Identified conflicts of interest are resolved by AKH prior to accreditation of the activity and may include any of or combination of the following: attestation to non-commercial content; notification of independent and certified CME expectations; referral to National Faculty Initiative training; restriction of topic area or content; restriction to discussion of science only; amendment of content to eliminate discussion of device or technique; use of other faculty for discussion of recommendations; independent review against criteria ensuring evidence support recommendation; moderator review; and peer review.
Disclosure of Unlabeled Use and Investigational Product
This educational activity may include discussion of uses of agents that are investigational and/or unapproved by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
This course is designed solely to provide the healthcare professional with information to assist in his/her practice and professional development and is not to be considered a diagnostic tool to replace professional advice or treatment. The course serves as a general guide to the healthcare professional, and therefore, cannot be considered as giving legal, nursing, medical, or other professional advice in specific cases. AKH Inc. and peerXchange Inc. specifically disclaims responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through participant's misunderstanding of the content.
A computer with an internet connection
Internet Browser: Internet Explorer 7.x or higher, Firefox 4.x or higher, Safari 2.x or higher, or any other W3C standards compliant browser
Other additional software may be required such as PowerPoint or Adobe Acrobat Reader.
Copyright 2019 peerXchange, Inc. No part of this publication may be produced, stored in a retrieval system, or transmitted in any form or by any means, electronic, mechanical photocopying, recording, or otherwise, without the prior permission of the publisher.
Continuing Medical Education and Continuing Education
When you register for a Continuing Medical Education (CME) or a Continuing Education (CE) activity through one of our Web sites, we collect certain personally identifiable information from you such as your name, email address and mailing address. If you are a pharmacist and wish to receive CE credit, you are also required to provide your NAPB # and month and day of birth. For more information about NABP and CPE Monitor click here. In addition to personally identifiable information, we collect aggregated non-personally identifiable information about the activities undertaken by our users. We use the information that we collect through CME/CE activities in several ways:
- We work with several accredited companies who are accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. As a joint-provider, we are required periodically to submit aggregated data about CME participants and the CME activities we certify. We also provide personally identifiable information to other accredited CME/CE providers who certify CME/CE activities posted on our Web sites, as required by the ACCME and other accrediting bodies. These reports may include personally identifiable information about you and credits issued to you, for the purpose of maintaining records that you can request from the accredited provider for up to six (6) years;
- Commercial supporters of CME/CE activities on our Web site will receive only aggregated data about CME/CE activities that are relevant to their interests and/or the courses they support;
- Our Editorial and Customer Support Staff will have internal access to files containing personally identifiable information, including evaluation forms and aggregated CME /CE participant information. These files can be accessed in order to respond to your questions or comments. Our staff may also use personally identifiable information, including registration information and evaluation data, in assessing educational needs and planning marketing activities.